Literature DB >> 32410144

Health-related quality of life of type 2 diabetes patients hospitalized for a diabetes-related complication.

Shuyan Gu1,2, Xiaoyong Wang3, Lizheng Shi4, Qiuying Sun5, Xiaoqian Hu1, Yuxuan Gu1, Xueshan Sun1, Hengjin Dong6.   

Abstract

PURPOSE: To estimate the health-related quality of life (HRQoL) of type 2 diabetes (T2DM) inpatients hospitalized for a complication in China and to explore the associated factors.
METHODS: This was a cross-sectional study. T2DM inpatients (aged ≥ 18 years) hospitalized for a complication, including ischemic heart disease (IHD), acute myocardial infarction (AMI), congestive heart failure (CHF), stroke, impaired vision, end-stage renal disease (ESRD), ulcer, and amputation were recruited from a tertiary hospital in China from January to May 2017. The EuroQoL-5 dimensions were used to measure HRQoL. A one-way analysis of variance and a multivariate regression analysis were performed.
RESULTS: Eight hundred and two T2DM inpatients hospitalized for a complication were included. The mean age was 62.67 years, and 43% of the inpatients were female. The mean utility-based HRQoL was 0.562 (95% CI 0.548, 0.577). The utility varied significantly between the complications: IHD = 0.620 (95% CI 0.597, 0.642), AMI = 0.434 (95% CI 0.394, 0.473), CHF = 0.471 (95% CI 0.433, 0.510), stroke = 0.472 (95% CI 0.436, 0.508), impaired vision = 0.714 (95% CI 0.692, 0.737), ESRD = 0.693 (95% CI 0.670, 0.717), ulcer = 0.431 (95% CI 0.375, 0.487), and amputation = 0.395 (95% CI 0.341, 0.448). Inpatients with a complication, who were female, and who had no daily exercise had a lower HRQoL.
CONCLUSIONS: The HRQoL of T2DM inpatients with a complication was considerably impaired. Our estimates provide supplementary data for public health and cost-effectiveness modeling, and increase the breadth of knowledge of HRQoL in T2DM.

Entities:  

Keywords:  Diabetes-related complication; EQ-5D; Health-related quality of life; Inpatient; Type 2 diabetes; Utility

Year:  2020        PMID: 32410144     DOI: 10.1007/s11136-020-02524-3

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  3 in total

1.  Investigating patients' preferences for new anti-diabetic drugs to inform public health insurance coverage decisions: a discrete choice experiment in China.

Authors:  Jinsong Geng; Haini Bao; Zhe Feng; Jingyi Meng; Xiaolan Yu; Hao Yu
Journal:  BMC Public Health       Date:  2022-10-05       Impact factor: 4.135

2.  Involvement of CircRNA Expression Profile in Diabetic Retinopathy and Its Potential Diagnostic Value.

Authors:  Hengqian He; Juntao Zhang; Weikun Gong; Mengyun Liu; Hao Liu; Xiaoyong Li; Yufei Wu; Qinkang Lu
Journal:  Front Genet       Date:  2022-02-17       Impact factor: 4.599

3.  Associations of Thyroid Hormone Levels and Macrovascular Complications in Euthyroid Type 2 Diabetic Patients.

Authors:  Yonghui Hu; Zhiyue Yan; Congqing Pan
Journal:  Diabetes Metab Syndr Obes       Date:  2021-06-15       Impact factor: 3.168

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.